{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:56:21Z","timestamp":1785232581159,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","archives-pmr.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.apmr.2015.01.025","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T03:30:20Z","timestamp":1437881420000},"page":"S256-S273.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"S","title":["Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury"],"prefix":"10.1016","volume":"96","author":[{"given":"Flora M.","family":"Hammond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald T.","family":"Seel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Kaelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-5184","authenticated-orcid":false,"given":"David K.","family":"Ryser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2015.01.025_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/02699050600743972","article-title":"The impact of acute care medications on rehabilitation outcome after traumatic brain injury","volume":"20","author":"Mysiw","year":"2006","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2015.01.025_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/02699050701559558","article-title":"Pharmacologic management of neurobehavioral sequelae of traumatic brain injury: a secondary survey of current physiatric practice","volume":"21","author":"Francisco","year":"2007","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2015.01.025_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apmr.2015.01.025_bib4","first-page":"145","article-title":"TRT: results after one year treatment","volume":"128","author":"Madeira","year":"2007","journal-title":"Laryngol Otol Rhinol"},{"key":"10.1016\/j.apmr.2015.01.025_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.7100929","article-title":"Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury","volume":"217","author":"Feeney","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.apmr.2015.01.025_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.lfs.2008.08.007","article-title":"Administration of haloperidol and risperdone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits","volume":"83","author":"Hoffman","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.apmr.2015.01.025_bib7","first-page":"219","article-title":"Neurobehavioral effects of phenytoin, carbamazepine, and valproic acid: implications for use in traumatic brain injury","volume":"72","author":"Massagli","year":"1991","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1176\/ajp.2006.163.9.1504","article-title":"SSRI-associated sexual dysfunction","volume":"163","author":"Balon","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.apmr.2015.01.025_bib9","series-title":"Seminars in clinical psychopharmacology","first-page":"573","article-title":"Unwanted effects of psychotropic drugs. Effects on human physiological systems, mechanisms and methods of assessment","author":"Edwards","year":"2004"},{"key":"10.1016\/j.apmr.2015.01.025_bib10","series-title":"Seminars in clinical psychopharmacology","first-page":"601","article-title":"Unwanted effects of psychotropic drugs. Drug interactions, effects during pregnancy and breast-feeding, pharmaco-vigilance and medico-legal considerations","author":"Edwards","year":"2004"},{"key":"10.1016\/j.apmr.2015.01.025_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/rnj.89","article-title":"Modifiable and nonmodifiable risk factors for falls after traumatic brain injury: an exploratory investigation with implications for medication use","volume":"39","author":"Murphy","year":"2014","journal-title":"Rehabil Nurs"},{"key":"10.1016\/j.apmr.2015.01.025_bib12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/02699050802320132","article-title":"Prescription medication use in persons many years following traumatic brain injury","volume":"22","author":"Yasseen","year":"2008","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2015.01.025_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0003-9993(97)90051-4","article-title":"Measurement and treatment of agitation following traumatic brain injury: II. A survey of the brain injury special interest group of the American Academy of Physical Medicine and Rehabilitation","volume":"78","author":"Fugate","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"issue":"8 Suppl 3","key":"10.1016\/j.apmr.2015.01.025_bib14","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.apmr.2014.09.042","article-title":"Traumatic Brain Injury\u2013Practice Based Evidence study: design and patients, centers, treatments, and\u00a0outcomes","volume":"96","author":"Horn","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.apmr.2004.11.041","article-title":"Measuring medical complexity during inpatient rehabilitation following traumatic brain injury","volume":"86","author":"Ryser","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10749357.1994.11754030","article-title":"Measurement characteristics of the functional independence measure","volume":"1","author":"Heinemann","year":"1994","journal-title":"Top Stroke Rehabil"},{"issue":"8 Suppl 3","key":"10.1016\/j.apmr.2015.01.025_bib17","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1016\/j.apmr.2015.04.020","article-title":"Predictors of agitated behavior during inpatient rehabilitation for traumatic brain injury","volume":"96","author":"Bogner","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"issue":"8 Suppl 3","key":"10.1016\/j.apmr.2015.01.025_bib18","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1016\/j.apmr.2014.11.030","article-title":"Traumatic brain injury patient, injury, therapy, and ancillary treatments associated with outcomes at discharge and 9 months postdischarge","volume":"96","author":"Horn","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.apmr.2010.08.029","article-title":"Cut point determination in the measurement of pain and its relationship to the psychosocial and functional measures after traumatic spinal cord injury: a retrospective model spinal cord injury system analysis","volume":"92","author":"Forchheimer","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib20","first-page":"557","article-title":"Pharmacologic treatment of cognitive and behavioral sequelae of traumatic brain injury: practicing in the absence of strong evidence","volume":"46","author":"Whyte","year":"2010","journal-title":"Eur J Phys Rehabil Med"},{"issue":"8 Suppl 3","key":"10.1016\/j.apmr.2015.01.025_bib21","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.apmr.2015.03.026","article-title":"Effects of patient preinjury and injury characteristics on acute rehabilitation outcomes for traumatic brain injury","volume":"96","author":"Corrigan","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"issue":"8 Suppl 3","key":"10.1016\/j.apmr.2015.01.025_bib22","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.apmr.2015.02.034","article-title":"Institutional variation in traumatic brain injury acute rehabilitation practice","volume":"96","author":"Seel","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib23","unstructured":"Ontario Neurotrauma Foundation. Evidence-based review of moderate to severe acquired brain injury. Available at: http:\/\/www.abiebr.com\/. Accessed May 20, 2015."},{"key":"10.1016\/j.apmr.2015.01.025_bib24","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/neu.2006.23.1468","article-title":"Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury","volume":"23","author":"Warden","year":"2006","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.apmr.2015.01.025_bib25","first-page":"26","article-title":"Pharmacological interventions for traumatic brain injury. Psychostimulants, antidepressants, and other agents may speed the recovery of patients suffering from the functional deficits that follow an insult to the brain","volume":"53","author":"Talsky","year":"2010","journal-title":"BCMJ"},{"key":"10.1016\/j.apmr.2015.01.025_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00002060-199711000-00002","article-title":"Effects of methylphenidate on attentional function after traumatic brain injury","volume":"76","author":"Whyte","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0003-9993(96)90291-9","article-title":"Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study","volume":"77","author":"Plenger","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1345\/aph.1E637","article-title":"Use of methylphedinate in traumatic brain injury","volume":"39","author":"Siddall","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.apmr.2015.01.025_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/026990599121061","article-title":"Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an\u00a0initial double-blind placebo-controlled study","volume":"13","author":"Schneider","year":"1999","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2015.01.025_bib30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00001199-200010000-00014","article-title":"Possible applications for dopaminergic agents following traumatic brain injury: part 1","volume":"15","author":"Zafonte","year":"2000","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00001199-200208000-00004","article-title":"Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial","volume":"31","author":"Meythaler","year":"2002","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00001199-200303000-00008","article-title":"The use of atypical antipsychotics in traumatic brain injury","volume":"18","author":"Elovic","year":"2003","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.apmr.2015.01.025_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/NRE-1999-13306","article-title":"Using atypical neuroleptic drugs to treat agitation in patients with brain injury: a review","volume":"13","author":"Burnett","year":"1999","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.apmr.2015.01.025_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/sim.2458","article-title":"Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment","volume":"26","author":"Leon","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.apmr.2015.01.025_bib35","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/sim.2732","article-title":"A comparison of mixed-effects quantile stratification propensity adjustment strategies for longitudinal treatment effectiveness analyses of continuous outcomes","volume":"26","author":"Leon","year":"2007","journal-title":"Stat Med"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999315003822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999315003822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T23:32:00Z","timestamp":1617319920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999315003822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0003999315003822"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2015.01.025","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2015.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}